Error message

Please enter some keywords.

Search returned 94346 results for “”

  1. Abstract

    Meeting Library

    Background: IL-17-producing CD4+ T helper (Th17) cells have recently been defined as a unique subset of proinflammatory helper cells whose development depends on signaling initiated by IL-6 and TGF-β, autocrine activity of IL-21, activation of STAT3, ...

    October 8, 2009

  2. Abstract

    Meeting Library

    Background: Addition of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab to first-line carboplatin (C) and paclitaxel (P) improved survival and objective response rate (ORR) of patients (pts) with advanced nonsquamous NSCLC and improved ...

    Author(s): Grace K. Dy

    June 4, 2010

  3. Abstract

    Meeting Library

    Background: Temsirolimus (T) has encouraging activity in many malignancies, including endometrial cancer and a combination with carboplatin and paclitaxel would logical regimen for further development. This trial was designed to assess the safety and toler ...

    Author(s): Amit M Oza

    June 1, 2009

  4. Abstract

    Meeting Library

    Background: 5-fluorouracil (5FU) and mitomycin-C (MMC) chemoradiation for anal cancer is an effective treatment strategy but is associated with significant acute morbidity that may be reduced by DP-IMRT. Methods: A multi-institutional phase II trial in T2- ...

    Author(s): Lisa A. Kachnic

    January 28, 2010

  5. Abstract

    Meeting Library

    Background: Incidental finding of pulmonary nodules on CT is frequent and application of cancer screening derived follow up (f/u) algorithms could produce multiple repeated scans with low yield, high cumulative cost and radiation burden. Rationale of curre ...

    Author(s): Orlando C Enrizo

    June 4, 2010

  6. Abstract

    Meeting Library

    Background: In order to simplify synthesis and labelling procedures and to improve the biological properties, we developed a novel mannose receptor-binding agent, Technetium-99m neomannosyl human serum albumin ( 99m Tc-MSA). This study was designed to test ...

    Author(s): Hyun Koo Kim

    June 1, 2009

  7. Abstract

    Meeting Library

    Background: Diffuse large B-cell lymphoma (DLBCL) usually relapses early following treatment but some relapses happen 5 years or later. Few data exist regarding clinical characteristics and outcome of these patients (pts). Methods: We performed a retrospec ...

    Author(s): Jean-Francois Larouche

    June 1, 2009

  8. Abstract

    Meeting Library

    Background: Chemotherapy regimens for metastatic esophagogastric cancers have been based on regimens used to treat gastric cancers with the backbone represented by cisplatin and 5-fluorouracil (5FU). OX and CAP are newer agents that are easier to administe ...

    Author(s): Hope E. Uronis

    January 28, 2010

  9. Abstract

    Meeting Library

    Background: Totally implantable access ports are often used for the administration of chemotherapy or prolonged intravenous infusions in patients with cancer. The technique has been well described. However, some complications would happen. Among others, th ...

    Author(s): Rossana Berardi

    January 28, 2010

  10. Abstract

    Meeting Library

    Background: A GM-CSF secreting allogeneic vaccine has been shown in phase I/II studies to be safe and effective in inducing antitumor immune response in pancreatic ductal adenocarcinoma (PDA) patients. Low-dose cyclophosphamide (Cy) may further enhance the ...

    Author(s): Lei Zheng

    January 28, 2010

Pages